Patient info

Wakix 4.5 mg film-coated tablets Wakix 18 mg film-coated tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM) ▼ Additional monitoring
Medicine strength:
4.5 mg
Other strengths and forms:
Contains active substance:
ATC code:

Patient leaflet - Wakix 4.5 mg film-coated tablets

1. What Wakix is and what it is used for

Wakix contains the active ingredient pitolisant. It is a medicine used to treat:

  • Adults, adolescents and children over the age of 6 years with

    narcolepsy, with or without cataplexy

  • Adult patients with obstructive sleep apnoea to treat excessive

    daytime sleepiness. It is used when sleepiness occurs despite treatment with continuous positive airway pressure (CPAP) or in patients who have not tolerated CPAP.

Narcolepsy is a condition that causes excessive daytime sleepiness and a tendency to suddenly fall asleep in inappropriate situations (sleep attacks). Cataplexy is the onset of sudden muscle weakness or paralysis without losing consciousness, in response to a sudden emotional reaction such as anger, fear, joy, laughter or surprise.

Obstructive sleep apnoea is a condition that causes you to stop breathing for at least 10 seconds during sleep. This can lead to excessive daytime sleepiness and a tendency to suddenly fall asleep in inappropriate situations (sleep attacks).

The active substance, pitolisant, attaches to receptors on cells in the brain that are involved in stimulating alertness. This helps to combat daytime sleepiness and cataplexy and promote wakefulness.

2. What you need to know before you take Wakix

Do not take Wakix if you

  • Are allergic to pitolisant or any of the other ingredients of this

    medicine (listed in section 6).

  • Have severe liver problems, as pitolisant is normally broken

    down in the liver and excess levels may build up in patients whose liver function is severely reduced.

  • Are breastfeeding.

Warnings and precautions

Talk to your doctor before taking Wakix if any of the situations mentioned below apply to you:

  • You ever had anxiety or depression with suicidal thoughts.
  • You have liver or kidney problems, as your dose may need to

    be adjusted.

    • You have a gastric ulcer or you take medicines that can irritate

      your stomach such as medicines against inflammations, since gastric reactions have been reported with Wakix.

    • You are obese or anorexic, as you may have change of your

      body weight (increase or decrease) while taking Wakix.

    • You have heart problems. Your doctor will need to check this

      regularly while you are taking Wakix.

    • You have severe epilepsy.

If any of these apply to you, talk to your doctor or pharmacist before taking Wakix.

Other things to talk to your doctor or pharmacist about: Some people with history of psychiatric disorders have reported having suicidal thoughts while taking this medicine. Tell your doctor straight away if you notice that you are becoming depressed or have suicidal thoughts (see section 4). You may want to consider asking a family member or close friend to help you look out for signs of depression or other changes in your behaviour.

Children

Wakix should not be taken by children less than 6 years old.

Other medicines and Wakix

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Wakix can affect the way other medicines work and other medicines can affect the way Wakix works. Your doctor may need to adjust your doses.

In particular, you should be cautious if you take Wakix together with some antidepressants (e.g. imipramine, clomipramine and mirtazapine) and some medicines to treat allergic conditions (anti-histamines, e.g. pheniramine maleate, chlorpheniramine, diphenydramine, promethazine, mepyramine, doxylamine).

Tell your doctor or pharmacist if you are taking any of the following medicines: rifampicin (an antibiotic), phenytoin, carbamazepine and phenobarbital (mainly used to control seizures), quinidine, digoxin (used to treat abnormal heart rhythms), paroxetine, fluoxetine, venlafaxine, duloxetine (antidepressants), St John’s Wort (Hypericum perforatum) (a herbal remedy for depression), bupropion (antidepressant or aid to smoking cessation), cinacalcet (for treatment of disorders of the parathyroid gland), terbinafine (used to treat fungal infections), metformin, repaglinide (used to treat diabetes), docetaxel, irinotecan (used to treat cancer), cisapride (used to treat gastric reflux), pimozide (used to treat some mental disorders), halofantrine (to treat malaria), efavirenz (antiviral medicine to treat HIV), morphine, paracetamol (used to treat pain), dabigatran (used to treat problems of the veins), warfarin (used to treat heart diseases), probenecid (used to treat gout and gouty arthritis).Pitolisant can be used with modafinil or sodium oxybate.

Wakix may reduce the effectiveness of hormonal contraceptives, an alternative method of effective contraception has to be used (see section “Pregnancy).

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Pregnancy

Wakix should not be used during pregnancy unless your doctor says so. There is not enough information available to know whether any particular risk is associated with the use of Wakix during pregnancy. If you are a woman, you have to take a contraceptive during your treatment with Wakix and at least up to 21 days after treatment discontinuation. As Wakix may reduce the effectiveness of hormonal contraceptive, an alternative method of effective contraception has to be used.

Breast-feeding

Wakix passes into breast milk in animals. Patients taking Wakix must stop breastfeeding.

Driving and using machines

You should be cautious with activities that require attention such as driving a car and handling machinery. If you are unsure whether your condition has a negative effect on your ability to drive, talk to your doctor.

3. How to take Wakix

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Adults

Treatment is normally started with a dose of 9 mg once per day, and gradually increased over three weeks to the most appropriate dose.

For a dose of 4.5 mg, take one 4.5 mg tablet.

For a dose of 9 mg, take two 4.5 mg tablets.

For a dose of 18 mg, take one 18 mg tablet.

For a dose of 36 mg, take two 18 mg tablets.

Adolescents and children over the age of 6

Treatment is normally started with a dose of 4.5 mg once per day, and gradually increased over three to four weeks to the most appropriate dose (see above).

If your weight is less than 40 kg, you should not take more than 18 mg per day.

Excessive daytime sleepiness in patients with obstructive sleep apnoea

Treatment is normally started with a dose of 4.5 mg once per day, and gradually increased over three weeks to the most appropriate dose. The maximum daily dose is 18 mg.

For a dose of 4.5 mg, take one 4.5 mg tablet.

For a dose of 9 mg, take two 4.5 mg tablets.

For a dose of 18 mg, take one 18 mg tablet.

At any time, your doctor can increase or decrease your dose depending on how well the medicine works for you and how well you tolerate it.

It might take a few days before you feel the benefit of the medicine and the maximum benefit is usually felt after a few weeks.

Do not change doses of Wakix on your own. Any change in dosage must be prescribed and monitored by your doctor.

Take Wakix once a day by mouth, in the morning upon wakening.

If you take more Wakix than you should

If you take too many tablets of Wakix, contact your nearest hospital casualty department or tell your doctor or pharmacist immediately. You may experience headaches, stomach pain, feeling sick or irritable. You may also have difficulty sleeping. Take this leaflet and any remaining tablets with you.

If you forget to take Wakix

If you forget to take your medicine take the next dose at the usual time, do not take a double dose to make up for the forgotten one.

If you stop taking Wakix

You should continue to take Wakix for as long as

instructed by your doctor. Do not stop taking Wakix suddenly on your own.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. If you notice any side effects, contact your doctor.

Front

Back

You should seek immediate medical attention if you experience any of these serious side effects:

  • Sudden and transient episode of muscle weakness, uncontrollable

    muscle spasms or movement of one leg

  • Epilepsy
  • Slow or fast heart rate, heart block or rhythm disorders

    (symptom include chest pain, lightheadedness, fainting, shortness of breath), abnormal reading (ECG) of the heart - Loss of consciousness

  • Feeling, seeing or hearing things that are not really there

    when you are awake or during sleep

  • Suicidal thoughts, feelings of emotional or mental discomfort
  • Inflammation of the digestive tract (symptoms include diarrhoea,

    swelling, fever, bloody stools)

  • Infection of the skin
  • Spontaneous abortion

Other side effects

Common side effects (may affect up to 1 in 10 people):

  • Difficulty in sleeping, feeling anxious, feeling depressed,

    sleeping problems, tiredness (fatigue)

  • Feeling of “spinning” (vertigo), loss of balance, trembling - Feeling sick, vomiting, indigestion

Uncommon side effects (may affect up to 1 in 100 people):

  • Decrease or increase of appetite, increase or decrease in weight - Oedema, tension
  • Feeling jittery, nervousness, feeling restless and unable to

    keep still, disturbance in attention

  • Changing emotions, state of indifference with lack of emotion,

    panic reaction, fear

  • Abnormal dreams, nightmare
  • Difficulty in falling asleep at the beginning of the night or in the

    middle of the night or at the end of the night, difficulty in staying asleep, sleep paralysis, excessive sleepiness, somnolence, trouble with sleep rhythm

  • Migraine
  • Altered or increased sexual interest
  • Movement disturbance, slow body movement, sudden and

    unpredictable phases of mobility and immobility, feeling unsteady, muscle rigidity, muscle weakness, spasms of muscles

  • Sensation of tingling, tickling, pricking, or burning of the skin
  • Reduced visual acuity, abnormal contraction or twitch of the eyelid,

    dry eye, presence of flashes of light or floaters in the vision - Hearing of sound when no external sound is present

  • Abnormal heart beat, palpitations, decrease blood pressure,

    abnormal heart rate, hot flush

  • Yawning, cough, shortness of breath at night, chest pain
  • Dry mouth, odour of the breath, changes in taste, high secretion

    of saliva, thirst

  • Constipation, discoloration of the faeces

    • Heartburn, stomach pain and discomfort, gastritis,

      excessive acidity of the gastrointestinal tract, rectal bleeding

    • Itching, skin condition of the face where the nose

      and cheeks are unusually red, sweating or excessive sweating, fever

    • Joint pain, back pain, pain of the muscle and

      the bones, pain in the toes and in the fingers, discomfort of arms and legs, pain of the tendons - Abnormal urination

  • Irregular uterine bleeding
  • Weakness, loss of strength or extreme tiredness, malaise
  • Abnormal blood values related to the function of the liver, change

    in bleeding analyses, increase of cholesterol levels or other fats in the blood seen in tests

  • Viral upper respiratory tract infection (common cold), cold sores

    • Alcohol intolerance, low blood sugar level
    • Withdrawal syndrome

Rare side effects (may affect up to 1 in 1000 people):

  • Loss or increased appetite, abdominal discomfort, difficulty or

    pain in swallowing

  • Abnormal behaviour, excitability, abnormal general physical

    condition

  • Tension headache, trouble with memory, poor sleep quality
  • Neck pain, pain around the chest area, sense of oppression
  • High blood level of the enzyme creatinine phosphokinase

If you are being treated for obstructive sleep apnoea, some of the following side effects may also occur:

Very common side effects (may affect more than 1 in 10 people): Headache

Common side effects (may affect up to 1 in 10 people): Raised blood pressure, diarrhoea, abdominal pain, discomfort or pain in the belly (abdomen), pain and discomfort, night sweats

Uncommon side effects (may affect up to 1 in 100 people): Flatulence, abnormally high sensitivity of the skin to sunlight, depressed mood, irritability, confusional state

If you are being treated for narcolepsy, some of the following side effects may also occur:

Common side effects (may affect up to 1 in 10 people): Headache, feeling irritable, dizziness

Uncommon side effects (may affect up to 1 in 100 people): Raised blood pressure, diarrhoea, abdominal pain, discomfort or pain in the belly (abdomen)

Rare side effects (may affect up to 1 in 1000 people): Pain, flatulence, night sweats, abnormally high sensitivity of the skin to sunlight, confusional state, depressed mood.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Wakix

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Wakix contains

The active substance is pitolisant.

Wakix 4.5 mg tablet

Each tablet contains pitolisant hydrochloride, equivalent to 4.45 mg of pitolisant

Wakix 18 mg tablet

Each tablet contains pitolisant hydrochloride, equivalent to 17.8 mg of pitolisant.

The other ingredients are microcrystalline cellulose, crospovidone Type A, talc, magnesium stearate, colloidal anhydrous silica, poly(vinyl alcohol), titanium dioxide (E 171), macrogol 3350.

What Wakix looks like and contents of the pack

Wakix 4.5 mg comes in a white, round, film-coated tablet of 3.7 mm, biconvex marked with “5” on one side.

Wakix 18 mg comes in a white, round, film-coated tablet of 7.5 mm, biconvex marked with “20” on one side.

Wakix is available in a bottle of 30 tablets or 90 tablets. Wakix 4.5 mg: Available in packs containing 1 bottle of 30 tablets. Wakix 18 mg: Available in packs containing 1 bottle of 30 tablets or packs containing 1 bottle of 90 tablets or multi-packs containing 90 (3 bottles of 30) tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Bioprojet UK Limited

Unit B Stanley Court

Glenmore Business Park

Telford Road

Salisbury

Wiltshire

SP2 7GH

Manufacturer

Wakix 18 mg

Inpharmasci

ZI N°2 de Prouvy-Rouvignies

1 rue Nungesser

59121 Prouvy

France

Wakix 4.5 mg

Patheon

40 Boulevard de Champaret 38300 Bourgoin-Jallieu France

This leaflet was last revised in October 2025

Package leaflet: Information for the patient

Wakix 4.5 mg film-coated tablets Wakix 18 mg film-coated tablets

pitolisant This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Adults, adolescents and children over the age of 6 years with narcolepsy, with or without cataplexy

Adult patients with obstructive sleep apnoea to treat excessive daytime sleepiness. It is used when sleepiness occurs despite treatment with continuous positive airway pressure (CPAP) or in patients who have not tolerated CPAP.

Are allergic to pitolisant or any of the other ingredients of this medicine (listed in section 6).

Have severe liver problems, as pitolisant is normally broken down in the liver and excess levels may build up in patients whose liver function is severely reduced.

Are breastfeeding.

You ever had anxiety or depression with suicidal thoughts. You have liver or kidney problems, as your dose may need to be adjusted. You have a gastric ulcer or you take medicines that can irritate your stomach such as medicines against inflammations, since gastric reactions have been reported with Wakix.

You are obese or anorexic, as you may have change of your body weight (increase or decrease) while taking Wakix.

You have heart problems. Your doctor will need to check this regularly while you are taking Wakix.

You have severe epilepsy.

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Wakix contains the active ingredient pitolisant. It is a medicine used to treat:

Talk to your doctor before taking Wakix if any of the situations mentioned below apply to you:

Narcolepsy is a condition that causes excessive daytime sleepiness and a tendency to suddenly fall asleep in inappropriate situations (sleep attacks). Cataplexy is the onset of sudden muscle weakness or paralysis without losing consciousness, in response to a sudden emotional reaction such as anger, fear, joy, laughter or surprise.

Obstructive sleep apnoea is a condition that causes you to stop breathing for at least 10 seconds during sleep. This can lead to excessive daytime sleepiness and a tendency to suddenly fall asleep in inappropriate situations (sleep attacks).

The active substance, pitolisant, attaches to receptors on cells in the brain that are involved in stimulating alertness. This helps to combat daytime sleepiness and cataplexy and promote wakefulness.

Do not take Wakix if you

Warnings and precautions

Children

Other medicines and Wakix

Pregnancy and breast-feeding

Driving and using machines

If any of these apply to you, talk to your doctor or pharmacist before taking Wakix.

Some people with history of psychiatric disorders have reported having suicidal thoughts while taking this medicine. Tell your doctor straight away if you notice that you are becoming depressed or have suicidal thoughts (see section 4). You may want to consider asking a family member or close friend to help you look out for signs of depression or other changes in your behaviour.

Other things to talk to your doctor or pharmacist about:

Pregnancy

Breast-feeding

Wakix should not be taken by children less than 6 years old.

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Wakix passes into breast milk in animals. Patients taking Wakix must stop breastfeeding.

You should be cautious with activities that require attention such as driving a car and handling machinery. If you are unsure whether your condition has a negative effect on your ability to drive, talk to your doctor.

Wakix should not be used during pregnancy unless your doctor says so. There is not enough information available to know whether any particular risk is associated with the use of Wakix during pregnancy. If you are a woman, you have to take a contraceptive during your treatment with Wakix and at least up to 21 days after treatment discontinuation. As Wakix may reduce the effectiveness of hormonal contraceptive, an alternative method of effective contraception has to be used. Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Wakix can affect the way other medicines work and other medicines can affect the way Wakix works. Your doctor may need to adjust your doses.

Wakix may reduce the effectiveness of hormonal contraceptives, an alternative method of effective contraception has to be used (see section “Pregnancy). In particular, you should be cautious if you take Wakix together with some antidepressants (e.g. imipramine, clomipramine and mirtazapine) and some medicines to treat allergic conditions (anti-histamines, e.g. pheniramine maleate, chlorpheniramine, diphenydramine, promethazine, mepyramine, doxylamine). Tell your doctor or pharmacist if you are taking any of the following medicines: rifampicin (an antibiotic), phenytoin, carbamazepine and phenobarbital (mainly used to control seizures), quinidine, digoxin (used to treat abnormal heart rhythms), paroxetine, fluoxetine, venlafaxine, duloxetine (antidepressants), St John’s Wort (Hypericum perforatum) (a herbal remedy for depression), bupropion (antidepressant or aid to smoking cessation), cinacalcet (for treatment of disorders of the parathyroid gland), terbinafine (used to treat fungal infections), metformin, repaglinide (used to treat diabetes), docetaxel, irinotecan (used to treat cancer), cisapride (used to treat gastric reflux), pimozide (used to treat some mental disorders), halofantrine (to treat malaria), efavirenz (antiviral medicine to treat HIV), morphine, paracetamol (used to treat pain), dabigatran (used to treat problems of the veins), warfarin (used to treat heart diseases), probenecid (used to treat gout and gouty arthritis).Pitolisant can be used with modafinil or sodium oxybate.

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Narcolepsy Adults

Treatment is normally started with a dose of 9 mg once per day, and gradually increased over three weeks to the most appropriate dose.

Adolescents and children over the age of 6

Treatment is normally started with a dose of 4.5 mg once per day, and gradually increased over three to four weeks to the most appropriate dose (see above). If your weight is less than 40 kg, you should not take more than 18 mg per day Excessive daytime sleepiness in patients with obstructive sleep apnoea Treatment is normally started with a dose of 4.5 mg once per day, and gradually increased over three weeks to the most appropriate dose. The maximum daily dose is 18 mg.

For a dose of 4.5 mg, take one 4.5 mg tablet.

For a dose of 9 mg, take two 4.5 mg tablets.

For a dose of 18 mg, take one 18 mg tablet.

For a dose of 36 mg, take two 18 mg tablets.

For a dose of 4.5 mg, take one 4.5 mg tablet.

For a dose of 9 mg, take two 4.5 mg tablets.

For a dose of 18 mg, take one 18 mg tablet.

At any time, your doctor can increase or decrease your dose depending on how well the medicine works for you and how well you tolerate it.

It might take a few days before you feel the benefit of the medicine and the maximum benefit is usually felt after a few weeks.

Do not change doses of Wakix on your own. Any change in dosage must be prescribed and monitored by your doctor.

Take Wakix once a day by mouth, in the morning upon wakening. What is in this leaflet?

1.

2.

3.

4.

5.

6.

If you take too many tablets of Wakix, contact your nearest hospital casualty department or tell your doctor or pharmacist immediately. You may experience headaches, stomach pain, feeling sick or irritable. You may also have difficulty sleeping. Take this leaflet and any remaining tablets with you. If you take more Wakix than you should

If you forget to take Wakix

If you forget to take your medicine take the next dose at the usual time, do not take a double dose to make up for the forgotten one.

  1. 5. How to store Wakix
  2. 6. Contents of the pack and other information

This leaflet was last revised in October 2025.

Reporting of side effects

If you are being treated for obstructive sleep apnoea, some of the following side effects may also occur:

If you are being treated for narcolepsy, some of the following side effects may also occur:

Very common side effects (may affect more than 1 in 10 people): Headache Common side effects (may affect up to 1 in 10 people): Raised blood pressure, diarrhoea, abdominal pain, discomfort or pain in the belly (abdomen), pain and discomfort, night sweats

Uncommon side effects (may affect up to 1 in 100 people): Flatulence, abnormally high sensitivity of the skin to sunlight, depressed mood, irritability, confusional state

Common side effects (may affect up to 1 in 10 people): Headache, feeling irritable, dizziness

Uncommon side effects (may affect up to 1 in 100 people): Raised blood pressure, diarrhoea, abdominal pain, discomfort or pain in the belly (abdomen) Rare side effects (may affect up to 1 in 1000 people): Pain, flatulence, night sweats, abnormally high sensitivity of the skin to sunlight, confusional state, depressed mood.

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.

What Wakix contains

What Wakix looks like and contents of the pack

Wakix 4.5 mg comes in a white, round, film-coated tablet of 3.7 mm, biconvex marked with “5” on one side.

Wakix 18 mg comes in a white, round, film-coated tablet of 7.5 mm, biconvex marked with “20” on one side.

Wakix is available in a bottle of 30 tablets or 90 tablets.

Wakix 4.5 mg: Available in packs containing 1 bottle of 30 tablets. Wakix 18 mg: Available in packs containing 1 bottle of 30 tablets or packs containing 1 bottle of 90 tablets or multi-packs containing 90 (3 bottles of 30) tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Bioprojet UK Limited

Unit B Stanley Court

Glenmore Business Park

Telford Road

Salisbury

Wiltshire

SP2 7GH

Manufacturer

Wakix 18 mg

Inpharmasci

ZI N°2 de Prouvy-Rouvignies

1 rue Nungesser

59121 Prouvy

France

Wakix 4.5 mg

Patheon

40 Boulevard de Champaret 38300 Bourgoin-Jallieu France

Keep this medicine out of the sight and reach of children.

The active substance is pitolisant.

The other ingredients are microcrystalline cellulose, crospovidone Type A, talc, magnesium stearate, colloidal anhydrous silica, poly(vinyl alcohol), titanium dioxide (E 171), macrogol 3350.

Wakix 4.5 mg tablet

Each tablet contains pitolisant hydrochloride, equivalent to 4.45 mg of pitolisant Wakix 18 mg tablet

Each tablet contains pitolisant hydrochloride, equivalent to 17.8 mg of pitolisant. Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

Sudden and transient episode of muscle weakness, uncontrollable muscle spasms or movement of one leg

Epilepsy

Slow or fast heart rate, heart block or rhythm disorders (symptom include chest pain, lightheadedness, fainting, shortness of breath), abnormal reading (ECG) of the heart

Loss of consciousness

Feeling, seeing or hearing things that are not really there when you are awake or during sleep

Suicidal thoughts, feelings of emotional or mental discomfort Inflammation of the digestive tract (symptoms include diarrhoea, swelling, fever, bloody stools)

Infection of the skin

Spontaneous abortion

Decrease or increase of appetite, increase or decrease in weight Oedema, tension

Feeling jittery, nervousness, feeling restless and unable to keep still, disturbance in attention

Changing emotions, state of indifference with lack of emotion, panic reaction, fear

Abnormal dreams, nightmare

Difficulty in falling asleep at the beginning of the night or in the middle of the night or at the end of the night, difficulty in staying asleep, sleep paralysis, excessive sleepiness, somnolence, trouble with sleep rhythm Migraine

Altered or increased sexual interest

Movement disturbance, slow body movement, sudden and unpredictable phases of mobility and immobility, feeling unsteady, muscle rigidity, muscle weakness, spasms of muscles

Sensation of tingling, tickling, pricking, or burning of the skin Reduced visual acuity, abnormal contraction or twitch of the eyelid, dry eye, presence of flashes of light or floaters in the vision

Hearing of sound when no external sound is present

Abnormal heart beat, palpitations, decrease blood pressure, abnormal heart rate, hot flush

Yawning, cough, shortness of breath at night, chest pain

Dry mouth, odour of the breath, changes in taste, high secretion of saliva, thirst Constipation, discoloration of the faeces

Heartburn, stomach pain and discomfort, gastritis, excessive acidity of the gastrointestinal tract, rectal bleeding

Itching, skin condition of the face where the nose and cheeks are unusually red, sweating or excessive sweating, fever

Joint pain, back pain, pain of the muscle and the bones, pain in the toes and in the fingers, discomfort of arms and legs, pain of the tendons Abnormal urination

Irregular uterine bleeding

Weakness, loss of strength or extreme tiredness, malaise

Abnormal blood values related to the function of the liver, change in bleeding analyses, increase of cholesterol levels or other fats in the blood seen in tests Viral upper respiratory tract infection (common cold), cold sores Alcohol intolerance, low blood sugar level

Withdrawal syndrome

Difficulty in sleeping, feeling anxious, feeling depressed, sleeping problems, tiredness (fatigue)

Feeling of “spinning” (vertigo), loss of balance, trembling

Feeling sick, vomiting, indigestion

Loss or increased appetite, abdominal discomfort, difficulty or pain in swallowing

Abnormal behaviour, excitability, abnormal general physical condition Tension headache, trouble with memory, poor sleep quality Neck pain, pain around the chest area, sense of oppression High blood level of the enzyme creatinine phosphokinase

Rare side effects (may affect up to 1 in 1000 people):

Common side effects (may affect up to 1 in 10 people):

Uncommon side effects (may affect up to 1 in 100 people): Like all medicines, this medicine can cause side effects, although not everybody gets them. If you notice any side effects, contact your doctor.

  1. 4. Possible side effects

You should seek immediate medical attention if you experience any of these serious side effects:

Other side effects

If you stop taking Wakix

You should continue to take Wakix for as long as instructed by your doctor. Do not stop taking Wakix suddenly on your own.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLGB 18813/0007

Last revision stated in the text: October 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Wakix 4.5 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Pitolisant
Strength 4.5 mg
Pharmaceutical form Oral tablet
White, round, biconvex film-coated tablet, 3.7 mm diameter, marked with “5” on one side.
How is it taken Oral
Excipients Microcrystalline cellulose, Crospovidone type A, Talc, Magnesium stearate, Colloidal anhydrous silica, Poly(vinyl alcohol), Titanium dioxide (E171), Macrogol 3350
Pack sizes 30 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Other nervous system drugs
  1. N Nervous system drugs
    1. N07 Other nervous system drugs
      1. N07X Other nervous system drugs
        1. N07XX Other nervous system drugs
          1. N07XX11 pitolisant
Additional monitoring Yes ▼ – new safety information is collected quickly. Report any side effect to the Yellow Card scheme.
Marketing authorisation PLGB 18813/0007 (first authorised 1 January 2021)
Marketing authorisation holder Bioprojet UK Limited
Codes GTIN 3760254600001 · BNF 04040000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.